Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Lancet
Alejandro Llanos-CuentasLynda Kellam

Abstract

Clinical effectiveness of previous regimens to treat Plasmodium vivax infection have been hampered by compliance. We aimed to assess the dose-response, safety, and tolerability of single-dose tafenoquine plus 3-day chloroquine for P vivax malaria radical cure. In this double-blind, randomised, dose-ranging phase 2b study, men and women (aged ≥16 years) with microscopically confirmed P vivax monoinfection (parasite density >100 to <100,000 per μL blood) were enrolled from community health centres and hospitals across seven sites in Brazil, Peru, India, and Thailand. Patients with glucose-6-phosphate dehydrogenase enzyme activity of less than 70% were excluded. Eligible patients received chloroquine (days 1-3) and were randomly assigned (1:1:1:1:1:1) by a computer-generated randomisation schedule to receive single-dose tafenoquine 50 mg, 100 mg, 300 mg, or 600 mg, primaquine 15 mg for 14 days, or chloroquine alone. Randomisation was stratified by baseline parasite count (≤7500 and >7500 per μL blood). The primary efficacy endpoint was relapse-free efficacy at 6 months from initial dose (ie, clearance of initial infection without subsequent microscopically confirmed infection), analysed by intention to treat. This study is registe...Continue Reading

References

Feb 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·C LuxemburgerF Nosten
Sep 14, 1956·Science·A S ALVINGC E ICKES
Oct 16, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Douglas S WalshSornchai Looareesuwan
Oct 22, 2008·European Journal of Medicinal Chemistry·Nuno ValePaula Gomes
Feb 6, 2010·Trends in Parasitology·Timothy N C WellsJ Kevin Baird
Oct 4, 2011·Journal of Parasitology Research·Ricardo AguasM Gabriela M Gomes
Oct 13, 2011·Malaria Journal·Nicholas J White
May 1, 2012·Malaria Journal·Nicholas M DouglasRic N Price
Aug 21, 2012·Malaria Journal·George K JohnRic N Price
May 25, 2013·British Journal of Clinical Pharmacology·Ann K MillerAndrew P Beelen
Jun 15, 2013·The Journal of Infectious Diseases·Nicholas M DouglasRic N Price

❮ Previous
Next ❯

Citations

Apr 16, 2014·Malaria Journal·Talita P C ChierritoAntoniana U Krettli
Apr 23, 2014·The American Journal of Tropical Medicine and Hygiene·Ric N Price
Apr 16, 2014·Malaria Journal·Katherine E BattleSimon I Hay
Jan 8, 2015·Expert Opinion on Investigational Drugs·Jana HeldAndrea Kreidenweiss
Oct 27, 2015·The Journal of Infectious Diseases·Hans-Peter BeckJustin A Green
Oct 3, 2015·Vaccine·Ivo MuellerChetan E Chitnis
Oct 21, 2014·Chemical Reviews·Cátia TeixeiraPaula Gomes
Nov 28, 2015·Trends in Molecular Medicine·Jean Popovici, Didier Ménard
Dec 2, 2015·Malaria Journal·Adam P McFarlandAndres G Lescano
Apr 5, 2016·Hematology/oncology Clinics of North America·Lucio LuzzattoRosario Notaro
May 7, 2015·Pathogens and Global Health·Sharmini Gunawardena, Nadira D Karunaweera
Apr 15, 2016·Pathogens and Global Health·Kumar Rishikesh, Kavitha Saravu
Oct 9, 2014·Malaria Research and Treatment·D D RajgorN A Kshirsagar
Jul 22, 2014·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Torben K BeckerUNKNOWN Global Emergency Medicine Literature Review (GEMLR) Group
May 23, 2015·Nature Reviews. Drug Discovery·Timothy N C WellsWesley C Van Voorhis
Jan 20, 2015·Future Microbiology·Francesca F NormanRogelio López-Vélez
May 15, 2015·PLoS Neglected Tropical Diseases·Sócrates HerreraMyriam Arévalo-Herrera
May 19, 2016·Expert Opinion on Pharmacotherapy·Nicholas J White
Nov 5, 2016·Infectious Diseases of Poverty·Akshaya Srikanth BhagavathulaAbdulla Shehab
Oct 22, 2016·Cell·Alan F CowmanKevin Marsh
Oct 23, 2016·Tropical Medicine & International Health : TM & IH·Henry Maia PeixotoMaria Regina Fernandes de Oliveira
Feb 15, 2017·American Journal of Hematology·N Scott ReadingJosef T Prchal
Nov 4, 2016·The American Journal of Tropical Medicine and Hygiene·Suiane NegreirosAlexandre Macedo de Oliveira
May 18, 2016·The American Journal of Tropical Medicine and Hygiene·G Dennis Shanks
Jun 11, 2015·Revista Da Sociedade Brasileira De Medicina Tropical·Vanderson Souza SampaioMarcus Vinícius Guimarães Lacerda
Sep 4, 2014·Memórias do Instituto Oswaldo Cruz·Marcus V G LacerdaRicardo Lourenço-de-Oliveira
Sep 4, 2014·Memórias do Instituto Oswaldo Cruz·Fernando Fonseca ValMarcus Vinícius Guimarães Lacerda
Aug 12, 2015·The American Journal of Tropical Medicine and Hygiene·Tamaki KobayashiJoseph M Vinetz
Nov 12, 2014·The American Journal of Tropical Medicine and Hygiene·Lyda OsorioJustin Green
Aug 21, 2014·Memórias do Instituto Oswaldo Cruz·Wuelton M MonteiroLacerda Marcus Vinícius G
Mar 20, 2015·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Maria KahnGonzalo J Domingo
Sep 13, 2017·Malaria Journal·Benedikt LeyRic N Price

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.